Tharimmune Stock (NASDAQ:THAR), Quotes and News Summary

Q: What sector and industry does Tharimmune (THAR) operate in?

Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Tharimmune Stock (NASDAQ: THAR) stock price, news, charts, stock research, profile.

Open	$0.358
Close	$0.369
Volume / Avg.	63.108K / 467.327K
Day Range	0.358 - 0.370
52 Wk Range	0.344 - 9.500
Market Cap	$4.362M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.65%
Days to Cover	1

Recent News

Tharimmune's Oral 'Under The Cheek' Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver Disease

Tharimmune achieves success in Phase 1 trial for TH104, a buccal film with nalmefene. Encouraging safety profile and potential for liver-related conditions.

Vandana Singh

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Tharimmune Inc

Sector

Health Care

Industry

Biotechnology

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tharimmune (THAR) stock?

You can purchase shares of Tharimmune (NASDAQ: THAR) through any online brokerage.

View our list of the best stock brokerages.

Who are Tharimmune's (THAR) competitors?

Other companies in Tharimmune’s space includes: Alzamend Neuro (NASDAQ:ALZN), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX), NexImmune (NASDAQ:NEXI) and Finch Therapeutics Gr (NASDAQ:FNCH).

What is the target price for Tharimmune (THAR) stock?

There is no analysis for Tharimmune.

Current Stock Price for Tharimmune (THAR)?

The stock price for Tharimmune (NASDAQ: THAR) is $0.37 last updated April 26, 2024 at 7:59 PM EDT.

Does Tharimmune (THAR) pay a dividend?

There are no upcoming dividends for Tharimmune.

When is Tharimmune (NASDAQ:THAR) reporting earnings?

Tharimmune’s Q1 earnings are confirmed for Monday, May 20, 2024.

Is Tharimmune (THAR) going to split?

There is no upcoming split for Tharimmune.

What sector and industry does Tharimmune (THAR) operate in?

Tharimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-